AI lifestyle coach tested for prediabetes: a 28-Day digital health experiment

NCT ID NCT07160985

Completed Disease control Sponsor: Li Huating Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed trial tested whether an AI-powered system called X Life could help adults with prediabetes improve their blood sugar control. Over 28 days, 131 participants either used the AI system for real-time diet and exercise recommendations or received standard lifestyle advice. The study measured changes in glucose tolerance to see if the AI approach was more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-based lifestyle management system (X Life)
What this could lead to: If it works, this could point toward a practical, non-drug tool to help people with prediabetes manage their blood sugar and potentially delay or prevent type 2 diabetes.
What could go wrong: This is a small, early-stage trial (131 people) testing a short-term intervention (28 days). The results may not be generalizable, and the AI system may not lead to lasting improvements or be better than standard lifestyle advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-DIABETES

Contacts and locations

Locations

Shanghai Sixth People's Hospital

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.